Biofrontera (BFRI) Gross Margin (2020 - 2025)
Historic Gross Margin for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 70.74%.
- Biofrontera's Gross Margin rose 248500.0% to 70.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.41%, marking a year-over-year decrease of 17100.0%. This contributed to the annual value of 50.14% for FY2024, which is 13400.0% up from last year.
- As of Q3 2025, Biofrontera's Gross Margin stood at 70.74%, which was up 248500.0% from 70.74% recorded in Q2 2025.
- In the past 5 years, Biofrontera's Gross Margin ranged from a high of 112.8% in Q4 2023 and a low of 77.84% during Q2 2023
- Its 5-year average for Gross Margin is 59.81%, with a median of 70.74% in 2025.
- Over the last 5 years, Biofrontera's Gross Margin had its largest YoY gain of 1850700bps in 2023, and its largest YoY loss of -1744300bps in 2023.
- Biofrontera's Gross Margin (Quarter) stood at 98.03% in 2021, then crashed by -174bps to 72.27% in 2022, then skyrocketed by 256bps to 112.8% in 2023, then crashed by -49bps to 58.03% in 2024, then grew by 22bps to 70.74% in 2025.
- Its last three reported values are 70.74% in Q3 2025, 70.74% for Q2 2025, and 61.95% during Q1 2025.